¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"net migration rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fetal heart rate
    žƽɹڼö
  • filtration rate
    ¿©°úºñ, ¿©°úÀ², ¿©°ú¼Óµµ
  • five-year survival rate
    ¿À³â»ýÁ¸À²
  • fixed rate pacemaker
    °íÁ¤¼Óµµ¹Úµ¿Á¶À²±â
  • flow rate
    1. À¯¼Ó 2. À¯·®
  • fractional fibrinogen catabolic rate
    ºÐȹº°¼¶À¯¼Ò¿ø´ë»çÀ²
  • frame rate
    È­¸é¹ß»ý·ü, È­¸éÀ²
  • general fertility rate
    ÀϹݻý½Ä·ü
  • glomerular filtration rate
    »ç±¸Ã¼¿©°úÀ², Å丮¿©°úÀ²
  • gross reproduction rate
    ÃÑÀç»ý»êÀ²
  • growth rate
    ¼ºÀå·ü
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • hazard rate
    À§Çè·ü
  • heart rate
    ½ÉÀå¹Úµ¿¼ö, ½É¹Ú¼ö
  • heart rate meter
    ½É¹Ú°è, ½ÉÀå¹Úµ¿°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • dose rate effect
    ¼±·®À²È¿°ú
  • dose rate meter
    ¼±·®À²°è, ¼±·®·üÃøÁ¤±â
  • dose rate variation
    ¼±·®·üº¯ÀÌ
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • energy fluence rate
    ¿¡³ÊÁöÇ÷ç¾ð½ºÀ², ¿¡³ÊÁö¿µÇâ·ü
  • energy metabolic rate
    ¿¡³ÊÁö´ë»çÀ²
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • exponential growth rate
    ´ë¼öÁõ½Ä·ü, Áö¼öÁõ½Ä·ü
  • exposure rate
    ÇÇÆø·ü
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü, ¼öÅÂÀ²
  • fetal death rate
    žƻç¸Á·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • rate of hardening
    °æÈ­¼Óµµ(ÌãûùáÜöô).
  • rate of polymerization
    ÁßÇÕ·ü(ñìùêëÒ).
  • rate of residual expansion
    ÀÜÁ¸ÆØÃ¢·ü(íÑðíø³óìëÒ).
  • rate of teeth decayed
    ¿ì½Ä·ü(ó»ãÚëÒ).
  • rate process
    ¼Óµµ°úÁ¤(áÜöôΦïï).
  • recombination rate
    Àç°áÇÕ·ü(¡­ëÒ).
  • red cell iron renewal rate
    ÀûÇ÷±¸Ã¶±³´ëÀ²(îåúìϹôÑÎßÓÛëÒ).
  • relative metabolic rate
    »ó´ëÀû ´ë»çÀ².
  • relative survival rate
    »ó´ë»ýÁ¸À²
  • relaxation rate
    ÀÌ¿ÏÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • continuous low dose rate irradiation
    Àú¼±·®À²¿¬¼Ó¹æ»ç¼±Á¶»ç
  • conversion rate
    ÀüȯÀ²(ï®üµëÒ).
  • conversion rate
    ÀüȯÀ²(ËøÌ·Ëô).
  • corrected death rate
    Á¤Á¤»ç¸Á·ü(ËøËøË×ËÎËô).
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü(ÊÙ̧Ë×Ëô).
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü(¡­õóßæëÒ).
  • crude birth rate
    Á¶Ãâ»ý·ü(̡̧Ë×Ëô).
  • crude birth rate
    Á¶Ãâ»ý·ü(ðØõóßæëÒ).
  • crude death rate
    Á¶»ç¸Á·ü(Ì¡Ë×ËÎËô).
  • crude fertility rate
    Á¶Ãâ»êÀ²(̡̧Ë×Ëô).
  • crude natural increase rate
    Á¶ÀÚ¿¬Áõ°¡À², º¸ÅëÀÚ¿¬Áõ°¡À²(ËÓ̬ËöËç̡˧Ëô)
  • crude survival rate
    Á¶»ýÁ¸À²
  • cumulative incidnce rate
  • cumulative survival rate
    ´©Àû»ýÁ¸À²
  • defect rate
    °áÇÔÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MMIF macrophage migration inhibitory factor
NM near-miss; neomycin; neuromedin; neuromuscular; neutrophil migration; nictitating membrane; nitrogen...
RM radical mastectomy; random migration; radon monitor; range of movement; red marrow; reference materi...
NAE net acid excretion
NAF nafcillin; National Amputation Foundation; National Ataxia Foundation; net acid flux
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LIF Leucocyte migration inhibition factor
LMT Leucocyte migration inhibiton test
LIF Leucocyte migration inhibitory factor
LMIF Leucocyte migration inhibitory factor
LMIF Leukocyte migration inhibition factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • stimulated parotid flow rate
    Àڱؼº ÀÌÇϼ± ºÐºñÀ²
  • survival rate
    »ýÁ¸À²
  • toddler mortality rate
    À¯¾Æ »ç¸Á·ü
  • tooth mortality rate
    Ä¡¾Æ »ó½Ç·ü
  • turnover rate
    ±³Ã¼À², ±³Ã¼ ¼Óµµ, ±³´ëÀ²
  • water absorption rate
    ¼öºÐ Èí¼öÀ²
    Èí¼öÀ²Àº Èí¼ö·®°ú °ÇÁ¶ Áß·®°úÀÇ ºñ·Î Ç¥½ÃµÈ´Ù. Áï
  • water-air exposure rate
    ¼ö°øÁßÁ¶»ç¼±·®ºñ, ¹°-°ø±âÁßÁ¶»ç¼±·®ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
maternal mortality rate The number of maternal deaths related to childbearing divided by the number of live births (or by the number of live births + foetal deaths) in that year. The maternal mortality rate in the united states in 1993 (and 1994) was 0.1 per 1,000 live births, or 1 mother dying per 10,000 live births.
(12 Dec 1998)
maximal expiratory flow rate <chest medicine, physiology> Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and fef 0.2-1.2.
Acronym: MEFR
(21 Jun 2000)
maximal midexpiratory flow rate Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%.
(12 Dec 1998)
glomerular filtration rate <nephrology> Measure of the kidneys' ability to filter and remove waste products.
(09 Oct 1997)
peak expiratory flow rate Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr.
(12 Dec 1998)
peak flow rate Maximum urinary flow rate during voiding as measured by a uroflowmeter.
(05 Mar 2000)
repetition rate The number of pulses per minute, describing an energy outpute.g., ultrasound pulses in echocardiography rather than vascular pulses.
(05 Mar 2000)
voiding flow rate Urinary flow as a function of time during micturition, as graphically recorded by a flow meter.
(05 Mar 2000)
volume loading rate The rate of raw materials put into a fermenter or aerobic digester, expressed in terms of material weight per unit volume per unit time.
(09 Oct 1997)
respiration rate Frequency of breathing, recorded as the number of breaths per minute.
(05 Mar 2000)
respiratory rate The number of breaths per minute (or, more formally, the number of movements indicative of inspiration and expiration per unit time). In practice, the respiratory rate is usually determined by counting the number of times the chest rises (or falls) per minute. By whatever means, the aim is to determine if the respirations are normal, abnormally fast (tachypnea), abnormally slow (technically termed bradypnea), or nonexistent (apnea).
(12 Dec 1998)
response rate <oncology> The percentage of patients showing partial or complete response to the given treatment.
(16 Dec 1997)
per capita rate <epidemiology> A rate which is proportional to the number of individuals in a population.
(05 Dec 1998)
perinatal mortality rate The number of stillborn infants of 24 completed weeks or more plus the number of deaths occurring under 7 days of life divided by the number of stillborn infants of 24 weeks or more gestation plus all liveborn infants in the same population, regardless of the period of gestation.
(05 Mar 2000)
metabolic clearance rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • floating exchange rate system
    º¯µ¿ ȯÀ²Á¦
  • floating rate
    ÀÚÀ¯ º¯µ¿ ½Ã¼¼;¼±Çϼ¼
  • forward rate
    (¿Ü±¹È¯ÀÇ) ¼±¹° ½Ã¼¼
  • freight rate
    ¿îÀÓ·ü Àå
  • fuel rate
    Ãʰ£ ¿¬·á ¼ÒºñÀ²
  • interest rate
    ±Ý¸®ÀÌÀ²
  • kill rate
    (ÀüÀï,Æøµ¿ µîÀÇ)»ì»ý·ü 9
  • milline rate
    1milline ´çÀÇ ±¤°í·á
  • minimum lending rate
    (¿µ)(À×±Û·£µå ÀºÇàÀÇ) ÃÖÀú ´ëÃ⠱ݸ®
  • poor rate
    ±¸ºó¼¼
  • prime rate
    (¹Ì±¹ ÀºÇàÀÌ 1·ù ±â¾÷¿¡ Àû¿äÇÏ´Â)Ç¥ÁØ ±Ý¸®
  • rate
    ºñÀ²;¿ä±Ý;½Ã¼¼;°¡°Ý;Æò°¡;¼Óµµ;Áøµµ;ÇÏ·çÀÇ ¿ÀÂ÷(½Ã°èÀÇ);¼¼±Ý;Áö¹æ¼¼;µî±Þ(¹è.¼±¿øÀÇ)...µî;Á¾·ù;Æò°¡ÇÏ´Ù;¾î¸²Àâ´Ù;...À¸·Î ¾Ë´Ù;À̶ó°í »ý°¢ÇÏ´Ù;(°ú¼¼¸¦ ¸ñÀûÀ¸·Î)...À» Æò°¡ÇÏ´Ù;...¿¡°Ô Áö¹æ¼¼¸¦ °úÇÏ´Ù;(¼±¿ø.¼±¹ÚÀÇ)µî±ÞÀ» Á¤ÇÏ´Ù;±Ô°ÝÀ» Á¤ÇÏ´Ù;(±â°èÀÇ)¿ÀÂ÷¸¦ Ãø
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
  • rate card
    ±¤°í ¿äÀ²Ç¥(±¤°í ¿ä±Ý.°ÔÀç ȸ¼ö.¿ø°í ¸¶°¨ÀÏ µîÀ» ¸í½ÃÇÑ Ç¥)
  • rate meter
    (°è¼ö±âÀÇ)°è¼öÀ²°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á